Eltanexor
- Generic Name
- Eltanexor
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H10F6N6O
- CAS Number
- 1642300-52-4
- Unique Ingredient Identifier
- Q59IQJ9NTK
- Background
Eltanexor is under investigation in clinical trial NCT02649790 (Study of the Safety, Tolerability and Efficacy of KPT-8602 in Patients With Relapsed/refractory Cancer Indications).
- Associated Conditions
- -
- Associated Therapies
- -
Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-05-06
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Vanderbilt-Ingram Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT06399640
- Locations
- 🇺🇸
Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath